Background and aims Plasma concentrations of endothelin-1 (ET-1), a potent pulmonary vasoconstrictor with a short serum half-life, can be estimated by measuring its stable by-product, C-terminal pro-Endothelin-1 (CT-proET-1). To investigate the association between CT-proET-1, gestational age, and pulmonary morbidity in newborn infants.
Methods A prospective cross-sectional study at two tertiary university hospitals was conducted. CT-proET-1 concentrations (pmol/L) were determined in plasma samples of 293 newborn infants (gestational age 24–41 weeks) at birth and on day 3 of life with BRAHMS KRYPTOR automated immunoflorescent assay.
Results At birth, CT-proET-1 concentrations were unrelated to birth weight and gestational age. Venous umbilical cord CT-proET-1 concentrations were consistently higher than matched arterial ones (M 148 vs. 134 pmol/L, p<0.001), but both values were closely related (RS=0.745, p<0.001). There was large postnatal increase of CT-proET-1 in infants with pulmonary morbidity. Days of mechanical ventilation, continuous positive airway pressure (CPAP), and oxygen supplementation correlated each with CT-proET-1 level on day 3 (RS 0.566, 0.658, and 0.819, respectively, for all p<0.001).
Conclusions In term and preterm newborn infants, pulmonary compromise is associated with increased concentrations of circulating CT-proET-1.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.